Aurora Cannabis Inc. - Common Shares (ACB)

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

The company also clarified it holds no material non-public information as it begins an internal probe into the source of the reports.

Aurora's CEO defends partnership with PMI-owned Aspeya, saying it's about science, not Big Tobacco. Here's what we learned.

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Cramer says Cerence is a winner and Aurora Cannabis is a nice speculative stock. He recommends owning NVIDIA over Skyworks. Sezzle's had its day. Build-A-Bear's results beat expectations. Republic Services is a great stock. HighPeak Energy is levered to oil prices.

Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.